James Cleland Quoted by Life Sciences Intellectual Property Review on Minerva v. Hologiv
- Cleland, James
- Media Mentions
James Cleland was recently quoted in Life Sciences Intellectual Property Review’s article, “Supreme Court Hears Minerva v Hologiv Arguments.” The US Supreme Court is currently discussing the potential abandoning of assignor estoppel after hearing oral arguments in this case. This case has drawn much attention due to its possible ramification its ruling could have on innovative industries with high employee turnover, including pharmaceutical and tech businesses. “It’s being watched particularly closely by the biopharma industry where there tends to be a lot of buying of small startups to import technology to give larger companies a certain market segment that they did not have before,” said James. Click here to read the full article.
Related Practices
Contacts
Recent Insights
- March 22, 2023 In the News Three Dickinson Wright Attorneys Named 2023 Texas Super Lawyers Rising Stars
- March 3, 2023 In the News Two Dickinson Wright Lawyers Listed in the 2023 Canadian Legal Lexpert® Directory
- February 28, 2023 Industry Alerts Trademark Scams
- February 14, 2023 Industry Alerts Canadian Patent Infringement: The Role of Non-Infringing Options in Profit Calculations and the Availability of Springboard Profits
- January 19, 2023 Industry Alerts Good News for Creators: Canada Extends Copyright Term
- January 17, 2023 In the News Jonathan Pollack Joins Dickinson Wright LLP
- January 11, 2023 In the News Damian Aquino and Corey Neil Join Dickinson Wright Troy Office
- December 15, 2022 Webinars Two New Tools to Enforce and Defend Your Company’s Trademark Rights
- December 12, 2022 In the News Bret McClay Named Of Counsel at Dickinson Wright